Minimally Invasive Surgery (Stereotactic Aspiration/Endoscopic) + rt-PA
Treatment for Intracerebral Hemorrhage
Typical Dosage: rt-PA (0.3mg in 1ml saline, q8h for up to 9 doses)
Effectiveness
65%
Safety Score
30%
Clinical Trials
1
Participants
1K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
rt-PA (0.3mg in 1ml saline, q8h for up to 9 doses)
Time to Effect
Days (over clot lysis)
Treatment Duration
Days (catheter in place)
Evidence Quality
MODERATENumber Needed to Treat (NNT)
15(Treat 15 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
25(Treat 25 patients to see 1 additional serious adverse event)
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$4,500
Monitoring:$40,000
Side Effect Mgmt:$5,000
Total Annual:$49,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$56,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$495,000
Minimally Invasive Surgery (Stereotactic Aspiration/Endoscopic) + rt-PA Outcomes
for Intracerebral Hemorrhage
Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+10%
Common Side Effects
Re-hemorrhage
+8%
Infection
+4%
Hydrocephalus
+7%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov